Mobile Investor

 Stock Information
Last Price: 1.04
Last Trade: 4:59 PM ET - Aug 28, 2015
Change: 0.02 down  (1.89%)
Open: 1.06
Close: 1.06
High: 1.09
Low: 1.04
52-Week High: 2.10
52-Week Low: 0.75
Volume: 805,820
 Recent News
Aug 27, 2015
Veloxis Pharmaceuticals A/S establishes new Warrant Programme
Aug 26, 2015
Veloxis Pharmaceuticals announces financial results for the first six months of 2015 and improves the full year outlook
Aug 14, 2015
Veloxis Pharmaceuticals Envarsus® XR Granted Orphan Drug Status by U.S. Food and Drug Administration for Kidney Transplant Rejection Prophylaxis
Jul 10, 2015
Veloxis Announces U.S. FDA Approval of Envarsus® XR for Treatment of Kidney Transplant Patients
Jun 24, 2015
Envarsus® XR Demonstrates Differentiated Pharmacokinetic Profile Compared to Twice-Daily Prograf® or Once-Daily Astagraf XL® in Stable Kidney Transplant Patients
 Events & Presentations
Nov 11, 2015
Interim Report for the 3rd Quarter – for the period 1 January to 30 September
Aug 27, 2015
Conference Call Announcing Interim Report for the second Quarter 2015
This is an optimized Investor Page for viewing on your mobile devices. To view our entire Investor Relations site, click here.
© 2015 Veloxis Pharmaceuticals AS